Skip to main content

Table 6 Bid-winning brands were used both before and after policy intervention

From: The impacts of national centralized drug procurement policy on drug utilization of medical institutions: an empirical study in a county-level hospital in China

No.

Round

Generic Name

DDDC

DDDs

Before

After

-76.40%***

13.48

13.14

-2.54%***

1

Second

Acarbose capsules

6.18

1.46

-62.08%***

30.25

23.18

-23.37%***

2

Third

Letrozole tablets

11.40

4.32

0.00%

15.00

26.25

75.00%

3

Fifth

Alfacalcidol tablets

2.46

2.46

-51.87%***

1.98

2.01

1.44%

4

Fifth

Iohexol injection

113.36

54.56

-21.31%***

1.28

1.21

-4.76%

5

Fifth

Misoprostol tablets

5.88

4.63

-76.40%***

13.48

13.14

-2.54%***

  1. Standard errors in parentheses
  2. ** p < 0.05 *** p < 0.01